
CVS Health Corp. (NYSE:CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.
What Happened: The Wall Street Journal reported the Woonsocket, Rhode Island-based CVS made its decision following an internal review of the two companies, citing concerns regarding excessive prescription orders for patients diagnosed with attention-deficit hyperactivity disorder (ADHD).